BRIEF published on 04/21/2025 at 17:50, 1 year 4 months ago Vanguard's Position in Direct Line Insurance Group Takeover Code Vanguard Group Shareholding Disclosure Direct Line Interest Positions
BRIEF published on 04/21/2025 at 17:50, 1 year 4 months ago Position de Vanguard dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Des Actions Ligne Directe Positions D'intérêt
PRESS RELEASE published on 04/21/2025 at 17:45, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.38% interest in Direct Line Insurance Group plc. Purchase of 10 10/11p ordinary shares at 2.74 GBP per unit Vanguard Group Stock Market Share Purchase Interest Disclosure Direct Line Insurance
BRIEF published on 04/17/2025 at 15:24, 1 year 4 months ago Le groupe Vanguard dévoile sa position dans Direct Line Insurance Investissement Code De Prise De Contrôle Divulgation Avant-garde Ligne Directe
BRIEF published on 04/17/2025 at 15:24, 1 year 4 months ago Vanguard Group Discloses Position in Direct Line Insurance Disclosure Investment Takeover Code Vanguard Direct Line
PRESS RELEASE published on 04/17/2025 at 15:19, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.38% ownership in Direct Line Insurance Group plc per Form 8.3 filing. Aviva plc also disclosed in relation to the offer Form 8.3 The Vanguard Group Ownership Disclosure Direct Line Insurance Group Plc Aviva Plc
BRIEF published on 04/16/2025 at 16:00, 1 year 4 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Takeover Code Securities Disclosure Vanguard Group Direct Line Insurance Aviva Plc
BRIEF published on 04/16/2025 at 16:00, 1 year 4 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Groupe Vanguard Code De Prise De Contrôle Divulgation Des Valeurs Mobilières Aviva Plc Assurance Direct Line
PRESS RELEASE published on 04/16/2025 at 15:55, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.38% ownership in Direct Line Insurance Group plc. They purchased 19,683 ordinary shares at 2.73 GBP per unit The Vanguard Group Ownership Disclosure Financial Disclosure Share Purchase Direct Line Insurance Group Plc
BRIEF published on 04/15/2025 at 16:27, 1 year 4 months ago Le groupe Vanguard révèle une participation significative dans Direct Line Insurance Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Des Stocks Assurance Direct Line
Published on 09/11/2026 at 04:00, 6 hours 15 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 50 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 55 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 15 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 54 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 9 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 15 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 3 hours 15 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 3 hours 15 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 3 hours 15 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 45 minutes ago Availability of the 2026 Interim Financial Report
